-
April 26, 2011 Lupin announces Patent License Agreement with Abbott
-
April 20, 2011 Lupin announces tentative FDA Approval for Metformin Hydrochloride extended-release tablets 500 mg and 1000 mg
-
March 15, 2011 Lupin to donate Yen 10 mn. for Japan’s earthquake victims
-
January 27, 2011 Lupin Net Profit up by 39 % in Q3, FY 2010-11 Sustained Growth, Strong Profits.
-
January 14, 2011 Lupin Announces Final FDA Approval for Nabumetone tablets, 500 mg and 750 mg.
-
January 5, 2011 LUPIN signs strategic agreement with FARMANGUINHOS, Brazil
-
January 3, 2011 Lupin Settles all Ongoing Litigation with Sunovion over Generic of LUNESTA® (eszopiclone)
-
November 2, 2010 Lupin Announces Litigation Settlement with Forest for Memantine Tablets
-
November 2, 2010 Lupin Announces Final FDA Approval for Suprax® (Cefixime) Chewable Tablets
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications